Management of breast pain

International Journal of Clinical Practice

Volumn 54, Issue 4, 2000, Pages 228-232

  Faiz, O ^a   Fentiman, Ian S ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BROMOCRIPTINE; DANAZOL; ERYTHROPOIETIN; GAMMA LINOLENIC ACID; GESTRINONE; GOSERELIN; LYNESTRENOL; MEDROXYPROGESTERONE ACETATE; MEFENAMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PROGESTERONE; PYRIDOXINE; TAMOXIFEN;

ACNE; BEHAVIOR THERAPY; BONE ATROPHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE CLASSIFICATION; DRUG CHOICE; HEADACHE; HIRSUTISM; HOT FLUSH; HUMAN; MAMMOGRAPHY; MASTALGIA; MENSTRUATION DISORDER; MENTAL DISEASE; PALLIATIVE THERAPY; PREMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; VAGINA DISCHARGE; VERTIGO;

BREAST DISEASES; BROMOCRIPTINE; DANAZOL; ESTROGEN ANTAGONISTS; FEMALE; HORMONE ANTAGONISTS; HUMANS; PAIN; PROGESTERONE; TAMOXIFEN;

EID: 0034105174     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Leinster SJ, Whitehouse GH, Walsh PV. Cyclical mastalgia: clinical and mammographic observations in a screened population. Br J Surg 1987; 74: 220-222.
2. Preece PE, Hughes LE, Mansel RE et al. Clinical syndromes of mastalgia. Lancet 1976; ii: 670-673.
3. Griffith CD, Dowle CS, Hinton CP et al. The breast pain clinic: a rational approach to classification and treatment of breast pain. Postgrad Med J 1987; 63(741): 547-549.
4. Maddox PR, Harrison BJ, Mansel RE et al. Non-cyclical mastalgia: an improved classification and treatment. Br J Surg 1989; 76: 901-904.
5. Fentiman IS. Tamoxifen and mastalgia: an emerging indication. Drugs 1986; 32: 477-480.
6. Wisbey JR, Kumar S, Mansel RE et al. The natural history of breast pain. Lancet 1983; ii: 672-674.
7. Ader DN, Shriver CD. Cyclical mastalgia: prevalence and impact in an outpatient breast clinic sample. J Am Coll Surg 1997; 185(5): 466-470.
8. Davies EL, Gateley CA, Miers M et al. The long term course of mastalgia. J R Soc Med 1998; 91(9): 462-464.
9. Hughes LE, Mansel RE, Webster DJT. Aberrations of normal development and involution (ANDI): a new perspective on pathogenesis and nomenclature of benign breast disorders. Lancet 1987; ii: 1316-1319.
10. Sitruk-Ware LR, Sterkers N, Mowszowics I et al. Inadequate corpus luteal function in women with benign breast disease. J Clin Endocrinol Metab 1977:44:771-774.
11. Walsh PV, Bulbrook RD, Stell PM et al. Serum progesterone concentration during the luteal phase in women with benign breast disease. Eur J Cancer Clin Oncol 1984; 20: 1339-1343.
12. Watl-Boolsen S, Anderson AN, Blichert-Toft M. Serum prolactin and oestradiol levels in women with cyclical mastalgia. Horm Metab Res 1981; 13: 700-702.
13. Walsh PV, McDicken IW, Bulbrook RD et al. Serum oestradiol-17 beta and prolactin concentrations during the luteal phase in women with benign breast disease. Eur J Cancer Clin Oncol 1984: 20(11): 1345-1351.
14. Watt-Boolsen S, Eskildsen PC, Blaehr H. Release of prolactin, thyrotropin, and growth hormone in women with cyclical mastalgia and fibrocystic disease of the breast. Cancer 1985; 56(3): 500-502.
15. Kumar S, Mansel RE, Hughes LE et al. Prolactin response to thyrotropin-releasing hormone stimulation and dopaminergic inhibition in benign breast disease. Cancer 1984; 53: 1311-1315.
16. Gateley CA, Maddox PR, Pritchard GA et al. Plasma fatty acid profiles in benign breast disorders. Br J Surg 1992; 79(5): 407-409.
17. Boyd NF, Shannon P, Kriukov V et al. Effect of a low-fat high-carbohydrate diet on symptoms of cyclical mastopathy. Lancet 1988; ii: 128-132.
18. Patey DH. Two common non-malignant conditions of the breast: the clinical features of cystic disease and the pain syndrome. BMJ 1949; 1: 96-99.
19. Jenkins PL, Jamil N, Gateley C et al. Psychiatric illness in patients with severe treatment-resistant mastalgia. Gen Hosp Psych 1993; 15: 55-57.
20. Downey HM, Deadman JM, Davis C et al. Psychological characteristics of women with cyclical mastalgia. Breast Dis 1993; 6: 99-105.
21. Ramirez AJ, Jarrett SR, Hamed H et al. Psychological adjustment of women with mastalgia. Breast 1995; 4: 48-51.
22. Fox H, Walker LG, Hayes SD et al. Are patients with mastalgia anxious, and does relaxation help? Breast 1997; 6: 138-142.
23. Preece PE, Baum M, Mansel RE et al. Importance of mastalgia in operable breast cancer. BMJ 1982; 284: 1299-1300.
24. Catania S, Zurrida S, Veronesi P et al. Mondor's disease and breast cancer. Cancer 1992; 69: 2267-2270.
25. O'Brien PM, Abukhalil IE. Randomised controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase-only danazol. Am J Obstet Gynecol 1999; 180: 18-23.
26. Pye JK, Mansel RE, Hughes LE. Clinical experience of drug treatments for mastalgia. Lancet 1985: ii: 373-376.
27. Mansel RE, Wisbey JR, Hughes LE. Controlled trial of the antigonadotrophin danazol in painful nodular benign breast disease. Lancet 1982; i: 928-930.
28. Doberl A, Tobiassen T, Rasmussen T. Treatment of recurrent mastodynia in patients with fibrocystic breast disease. Acta Obstet Gynecol Scand Suppl 1984; 123: 177-184.
29. Mansel RE, Preece PE, Hughes LE. A double-blind trial of the prolactin inhibitor bromocriptine in painful benign breast disease. Br J Surg 1978; 65: 724-727.
30. Blichert-Toft M, Nyobe Anderson AN, Hendriksen OB, Mygind T. Treatment of mastalgia with bromocriptine: a double-blind crossover study. BMJ 1979; 1: 237.
31. Durning P, Sellwood RA. Bromocriptine in severe cyclical breast pain. Br J Surg 1982; 69: 248-249.
32. Mansel RE, Dogliotti L. European multicentre trial of bromocriptine in cyclical mastalgia. Lancet 1990; 335: 190-193.
33. Hinton CP, Bishop HM, Holliday HW et al. A double-blind controlled trial of danazol and bromocriptine in the management of severe cyclical breast pain. Br J Clin Pract 1986; 40: 326-330.
34. Euhus DM, Uyehara C. Influence of parenteral progesterones on the prevalence and severity of mastalgia in premenopausal women: a multi-institutional cross-sectional study. J Am Coll Surg 1997; 184(6): 596-604.
35. Maddox PR, Harrison BJ, Horobin JM et al. A randomised controlled trial of medroxyprogesterone acetate in mastalgia. Ann R Coll Surg Engl 1990; 72: 71-76.
36. McFayden IJ, Raab GM, Macintyre CCA, Forrest APM. Progesterone cream for cyclic breast pain. BMJ 1989; 298: 931.
37. Nappi C, Affinito P, Di Carlo C et al. Double-blind controlled trial of progesterone vaginal cream treatment for cyclical mastodynia in women with benign breast disease. J Endocrinol Invest 1992; 15: 801-806.
38. Peters F. Multicentre study of gestrinone in cyclical breast pain. Lancet 1992; 339: 205-208.
39. Hamed H, Caleffi M, Chaudary MA et al. LHRH analogue for treatment of recurrent and refractory mastalgia. Ann R Coll Surg Engl 1990; 72(4): 221-224.
40. Hamed H, Fogelman I, Smith P, Gregory W, Fentiman IS. Effect of a GnRH analogue on bone mass in premenopausal patients with mastalgia. Breast 1993; 2: 79-82.
41. Fentiman IS, Caleffi M, Brame K et al. Double-blind controlled trial of tamoxifen therapy for mastalgia. Lancet 1986; i: 287-288.
42. Messinis IE, Lolis D. Treatment of premenstrual mastalgia with tamoxifen. Acta Obstet Gynecol Scand 1988; 67: 307-309.
43. Fentiman IS, Caleffi M, Hamed H et al. Dosage and duration of tamoxifen treatment for mastalgia: a controlled trial. Br J Surg 1988; 75(9): 845-846.
44. Powles TJ, Ford HT, Gazet J-C. A randomized trial to compare tamoxifen with danazol for treatment of benign mammary dysplasia. Breast Dis 1987; 2: 1-5.
45. Kontostolis E, Stefanidis K, Navrozoglou I, Lolis D. Comparison of tamoxifen with danazol for treatment of cyclical mastalgia. Gynecol Endocrinol 1997; 11: 393-397.
46. Sandrucci S, Mussa A, Festa V et al. Comparison of tamoxifen and bromocriptine in management of fibrocystic breast disease: a randomized blind study. Ann NY Acad Sci 1990; 586: 626-628.
47. GEMB Group (Grupo de Estudio de Mastopatias Benignas), Argentine. Tamoxifen therapy for cyclical mastalgia: dose randomized trial. Breast 1997; 5: 212-213.
48. Preece PE, Hanslip JI, Gilbert L et al. Evening primrose oil (Efamol) for mastalgia. In: Horrobin D, Ed. Clinical uses of essential fatty acids. New York: Eden Press, 1982.
49. Cheung KL. Management of cyclical mastalgia in oriental women: pioneer experience of using gamolenic acid (Efamast) in Asia. Aust NZ J Surg 1999; 69(7): 492-494.
50. Wetzig NR. Mastalgia: a 3 year Australian study. Aust NZ J Surg 1994; 64(5): 329-331.
51. Smallwood J, Kye D, Taylor I. Vitamin B6 in the treatment of premenstrual mastalgia. Br J Clin Pract 1986; 40: 532-533.
52. Ernster VL, Goodson WH, Hunt TK et al. Vitamin E and benign breast 'disease': a double-blind randomized trial. Surgery 1984; 97: 490-494.
53. Colin C, Gaspard U, Lambotte R. Relationship of mastodynia with its endocrine environment and treatment in a double-blind trial with lynestrenol. Arch Gynakol 1978; 225: 7-13.
54. Ernster VL, Mason L, Goodson WH et al. Effects of caffeine-free diet on benign breast disease: a randomized trial. Surgery 1982; 91: 263-267.
55. Gunston KD. Premenstrual syndrome in Capetown. Part II. A double-blind placebo-controlled study of the efficacy of mefenamic acid. S Afr Med J 1986; 70: 159-160.
56. Irving AD, Morrison SL. Effectiveness of topical non-steroidal anti-inflammatory drugs in the management of breast pain. J R Coll Surg Edin 1998; 43(3): 158-159.